Last week, Endpoints News executive editor Drew Armstrong sat down with Sanofi CEO Paul Hudson in Boston at the company’s expansive complex. They spoke about how the company is using AI across its business, Sanofi’s plans for the consumer unit it announced last year that it plans to divest, a hint about the company’s very early pipeline, and much more.
The hour-long conversation has been substantially edited for length and clarity.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.